Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment
A Position Paper of The Obesity Society and the American Society of Hypertension
Version of Record online: 18 DEC 2012
© 2012 Wiley Periodicals, Inc.
The Journal of Clinical Hypertension
Volume 15, Issue 1, pages 14–33, January 2013
How to Cite
Landsberg, L., Aronne, L. J., Beilin, L. J., Burke, V., Igel, L. I., Lloyd-Jones, D. and Sowers, J. (2013), Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment. The Journal of Clinical Hypertension, 15: 14–33. doi: 10.1111/jch.12049
- Issue online: 3 JAN 2013
- Version of Record online: 18 DEC 2012
- Manuscript received: October 12, 2012; accepted: October 18, 2012
In light of the worldwide epidemic of obesity, and in recognition of hypertension as a major factor in the cardiovascular morbidity and mortality associated with obesity, The Obesity Society and the American Society of Hypertension agreed to jointly sponsor a position paper on obesity-related hypertension to be published jointly in the journals of each society. The purpose is to inform the members of both societies, as well as practicing clinicians, with a timely review of the association between obesity and high blood pressure, the risk that this association entails, and the options for rational, evidenced-based treatment. The position paper is divided into six sections plus a summary as follows: pathophysiology, epidemiology and cardiovascular risk, the metabolic syndrome, lifestyle management in prevention and treatment, pharmacologic treatment of hypertension in the obese, and the medical and surgical treatment of obesity in obese hypertensive patients.